AIMEE SANCHEZ: Open Payments
NPI 1851175087 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,154 in 49 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $331 · 2025 $1,154
Food & beverage: $976Education: $178
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $246 |
| Janssen Biotech, Inc. | 5 | $190 |
| Amgen Inc. | 5 | $164 |
| Novartis Pharmaceuticals Corporation | 7 | $143 |
| UCB, Inc. | 5 | $126 |
| ABBVIE INC. | 3 | $61 |
| GENZYME CORPORATION | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| LEO Pharma Inc. | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
Products named: DUPIXENT, TREMFYA, OTEZLA, Bimzelx, COSENTYX, SKYRIZI, SPEVIGO, ADBRY.
Industry payments across CA — which companies pay providers there.
